Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report.
about
Dendritic cell vaccines for brain tumorsImmunotherapy advances for glioblastomaAn update on vaccine therapy and other immunotherapeutic approaches for glioblastomaTumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM Patients.Advances in treatment of pediatric brain tumorsOverview of cellular immunotherapy for patients with glioblastoma.Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial.Cellular and vaccine therapeutic approaches for gliomasStratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination.The future of high-grade glioma: Where we are and where are we going.Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation.Dendritic cell vaccination in glioblastoma after fluorescence-guided resectionSurgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study.Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferationDC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.Classifying Glioblastoma Multiforme Follow-Up Progressive vs. Responsive Forms Using Multi-Parametric MRI Features.Dendritic cell therapy of high-grade gliomas.Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paperWilms' Tumour gene 1 (WT1) as an immunotherapeutic targetChallenges in immunotherapy presented by the glioblastoma multiforme microenvironment.Dendritic cell vaccination in pediatric gliomas: lessons learnt and future perspectives.Brain Tumor Immunotherapy: What have We Learned so Far?Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma.Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours.A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial.
P2860
Q24641823-C5CEDB23-F1A8-48D3-BD90-6B8345BBE27FQ26866513-4C20B4C7-2F1A-4434-A7E0-5829A89AD89FQ27024830-C74E81D9-831F-40E4-8D56-4FB09409EE17Q30998509-5FD7245D-CCF3-4BB6-A713-36D2EB6F156EQ33237311-552F33AA-4655-4DEF-A0BE-25E73A2855B7Q34189694-E466EDD8-1226-4758-A5E5-3F7675151FCCQ34242939-88CBA97C-46F2-46AE-B021-1EED5BDBA83DQ34243550-4BA99616-3E3C-4282-9D02-4E0CC6BD1830Q34260758-C6BC7B08-FD80-4CE3-AE09-2DE72948E470Q35114090-8F3B12F4-69FD-4CBD-8861-49E55289FC1EQ35236790-F41DB006-2F48-4948-AA47-898230E064E0Q36507978-9994CF1B-0DDF-426C-B8C2-CC3339372672Q36695932-E59A2634-1BD9-4E31-A971-D60FFE63161CQ36968300-63CD27B0-26DE-4A74-AD71-C5A16BAFBEECQ37395354-F097BA23-51FC-4E14-9954-108C891504D4Q37578230-A5A06C5E-35A9-42C3-88DE-A329153AB05AQ37594834-B2ABD712-EC28-414E-93BA-406D747D2F6CQ37608106-84698F76-4460-453A-A98E-E678E35183BFQ37704104-7990CC53-5DF3-4A06-AEA8-66F29FC41C8CQ37970682-7940C657-AF9D-4A98-9B15-8957C5075DADQ38176625-99C85AB3-FFA9-42DC-A9FA-288407476BA5Q38542113-35681827-AE20-4527-8C68-A2FC354E2E98Q38912265-14EF10FA-716D-4095-A138-E1A9BA21D32EQ41391698-D7826A01-1B09-4751-9728-67913429C76AQ43166491-9E22D7CA-DC59-4297-AD06-C36001A90AC2Q43256128-10082B50-9C72-432B-A204-FC1ADE2CDCE5Q54980235-AD54B91D-205E-42DF-BA45-D1F902ABA265
P2860
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Transient local response and p ...... tic cell therapy. Case report.
@en
Transient local response and p ...... tic cell therapy. Case report.
@nl
type
label
Transient local response and p ...... tic cell therapy. Case report.
@en
Transient local response and p ...... tic cell therapy. Case report.
@nl
prefLabel
Transient local response and p ...... tic cell therapy. Case report.
@en
Transient local response and p ...... tic cell therapy. Case report.
@nl
P2093
P1476
Transient local response and p ...... tic cell therapy. Case report.
@en
P2093
Christian Plets
Eckhart Kaempgen
Frank Van Calenbergh
Johannes E Wolff
Patrick Flamen
Philippe Demaerel
Stefaan W Van Gool
Stefan Rutkowski
P304
P356
10.3171/PED.2004.100.5.0492
P407
P433
5 Suppl Pediatrics
P577
2004-05-01T00:00:00Z